AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

EMBARK EARLY EDUCATION LTD

0.410

0.000

Volume:27.13K

Turnover:11.12K

Market Cap:83.43M

PE:-13.10

High:0.410

Open:0.405

Low:0.405

Close:0.410

52wk High:0.621

52wk Low:0.362

Shares:203.48M

Float Shares:148.49M

Volume Ratio:0.38

T/O Rate:0.02%

Dividend:0.03

Dividend Rate:7.32%

EPS(TTM):-0.031

EPS(LYR):0.058

ROE:-6.67%

ROA:5.60%

PB:0.95

PE(LYR):7.06

Loading ...

Overview Company News Filings

Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment

MT Newswires Live

Australia's Embark Early Education Falls on Trading Ex-Dividend

Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors

MT Newswires Live

Embark Early Education Secures AU$4 Million Through Share Placement

MT Newswires Live

Embark Early Education - Receives A$4.0 Mln Placement Commitment at A$0.40 Per Share

THOMSON REUTERS

Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40

MT Newswires Live

Evotec Expands Prefabricated Drug Manufacturing Offerings

MT Newswires Live

Embark Early Education Declares Further Final Dividend

MT Newswires Live

Embark Early Education Declares QTRLY Dividend Of A$0.015/Share As Final Dividend For Fy2025

Embark Early Education Ltd - Declares Qtrly Dividend of AUD0.015 per Share as Final Dividend for FY2025

THOMSON REUTERS

Evotec, Almirall Nominate First Preclinical Development Candidate in Dermatology Partnership; Shares Up Pre-Bell

MT Newswires Live

Evotec Secures Grants for Tuberculosis Drug Development

MT Newswires Live

Evotec Names Claire Hinshelwood Chief Financial Officer

MT Newswires Live

Evotec Names Ingrid Muller Chief Operating Officer

MT Newswires Live

Evotec Q4 Revenue Rises; 2026 Sales Outlook Set; Shares Up Pre-Bell

MT Newswires Live

GUIDANCE: (EVO) Evotec SE Expects 2026 Revenue Range 700M Euros to 780M Euros

MT Newswires Live

Earnings Flash (EVO) Evotec Posts Q4 Revenue 253.3M Euros

MT Newswires Live

Evotec Unit Selected to Optimize Manufacturing for Antibody Cocktail

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/EVO.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EVO.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EVO.AU\",,,,,undefined,":{"symbol":"EVO.AU","market":"AU","secType":"STK","nameCN":"EMBARK EARLY EDUCATION LTD","latestPrice":0.41,"timestamp":1789091200538,"preClose":0.41,"halted":0,"volume":27133,"delay":0,"changeRate":0,"nameEN":"EMBARK EARLY EDUCATION LTD","floatShares":148489695,"shares":203481900,"eps":-0.031286,"marketStatus":"Trading","change":0,"latestTime":"09-11 11:47:49 AEST","open":0.405,"high":0.41,"low":0.405,"amount":11124,"amplitude":0.012195,"askPrice":0.41,"askSize":4080,"bidPrice":0.405,"bidSize":2080,"shortable":3,"etf":0,"ttmEps":-0.031286,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789106400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.41,"dividendRate":0.073171,"openAndCloseTimeList":[[1789084800000,1789106400000]],"volumeRatio":0.375676,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"EVO.AU","preClose":0.415,"auctionPrice":0.42,"auctionVolume":16928,"auction":3,"marketStatus":"盘后竞价","timestamp":1788934206745}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"EVO.AU\",,,,,undefined,":{"symbol":"EVO.AU","floatShares":148489695,"roa":"5.60%","roe":"-6.67%","lyrEps":0.0581,"volumeRatio":0.375676,"shares":203481900,"dividePrice":0.03,"high":0.41,"amplitude":0.012195,"preClose":0.41,"low":0.405,"week52Low":0.362,"pbRate":"0.95","psRate":"0.81","week52High":0.621,"institutionHeld":0,"latestPrice":0.41,"committee":-0.324675,"eps":-0.031286,"divideRate":0.073171,"volume":27133,"delay":0,"ttmEps":-0.031286,"open":0.405,"prevYearClose":0.567,"prevWeekClose":0.42,"prevMonthClose":0.435,"prevQuarterClose":0.377,"fiveDayClose":0.42,"twentyDayClose":0.401,"sixtyDayClose":0.372,"dividendPayoutRate":1.0320094944873492,"dividendFrequency":"A","dividendGrowthYears":3,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.09525962541474083},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EVO.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-04","symbol":"EVO.AU","amount":0.015,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-07","defaultRemindTime":1788480000000,"name":"EMBARK EARLY EDUCATION LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-21","payableDate":"2026-09-07","currency":"AUD","dateTimestamp":1788444000000,"payDate":"2026-09-21"},{"date":"2026-05-25","symbol":"EVO.AU","amount":0.015,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-05-26","defaultRemindTime":1779667200000,"name":"EMBARK EARLY EDUCATION LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-15","payableDate":"2026-05-26","currency":"AUD","dateTimestamp":1779631200000,"payDate":"2026-06-15"},{"date":"2026-03-03","symbol":"EVO.AU","amount":0.015,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-04","name":"EMBARK EARLY EDUCATION LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-04","currency":"AUD","dateTimestamp":1772456400000,"payDate":"2026-03-23"},{"date":"2025-11-25","symbol":"EVO.AU","amount":0.015,"announcedDate":"2025-11-20","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-11-26","name":"EMBARK EARLY EDUCATION LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-11-26","currency":"AUD","dateTimestamp":1763989200000,"payDate":"2025-12-17"},{"date":"2025-08-28","symbol":"EVO.AU","amount":0.015,"announcedDate":"2025-08-25","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-08-29","defaultRemindTime":1756339200000,"name":"EMBARK EARLY EDUCATION LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-08-29","currency":"AUD","dateTimestamp":1756303200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EVO.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2022-11-23","recordDate":"2022-11-24","paymentDate":"2022-12-08","value":0.006176,"currency":"NZD"},{"executeDate":"2023-07-19","recordDate":"2023-07-20","paymentDate":"2023-08-10","value":0.02,"currency":"AUD"},{"executeDate":"2023-11-06","recordDate":"2023-11-07","paymentDate":"2023-11-28","value":0.02,"currency":"AUD"},{"executeDate":"2024-03-05","recordDate":"2024-03-06","paymentDate":"2024-03-26","value":0.015,"currency":"AUD"},{"executeDate":"2024-05-10","recordDate":"2024-05-13","paymentDate":"2024-06-03","value":0.015,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EVO.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666839555","title":"Evotec Initiates Phase 1 Trial of Potential Smallpox, Mpox Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666839555","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666839555?lang=en_us&edition=fundamental","pubTime":"2026-09-09 15:52","pubTimestamp":1788940327,"startTime":"0","endTime":"0","summary":"Evotec (EVO) has initiated a phase 1 clinical trial evaluating JST-018, a cocktail of investigational monoclonal antibodies targeting orthopoxviruses, the company said Wednesday.The medicine was devel","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7132","BK4121","EVO","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664038522","title":"Australia's Embark Early Education Falls on Trading Ex-Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2664038522","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664038522?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:23","pubTimestamp":1788492219,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Embark Early Education falls on trading ex-dividend** Shares of Embark Early Education LtdEVO.AXfall as much as 6.8% to A$0.41, their lowest level since August 28** Stock on track for its worst day since August 17, if trends hold** Stock of the childhood education provider trades ex-dividend** Company had declared fully franked dividend of 1.5 Australian cents per share as interim dividend for FY25/26** Stock down 32% this year, including the day's move","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4N44W06U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7132","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818231","title":"Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818231","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818231?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343511,"startTime":"0","endTime":"0","summary":"Evotec  and Plectonic Biotech have entered a research collaboration to develop next-generation T-cell-engaging immunotherapies for solid tumors, the companies said Wednesday.The partnership will combine Evotec's BiTco platform with Plectonic's Logibody technology to address challenges that have limited traditional T-cell engagers in solid tumors, they said.Under the deal, the companies will generate preclinical proof-of-concept data to assess the potential of these T-cell engaging approaches, they added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7132","EVO.AU","BK4121","EVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656374585","title":"Embark Early Education Secures AU$4 Million Through Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2656374585","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656374585?lang=en_us&edition=fundamental","pubTime":"2026-08-04 09:09","pubTimestamp":1785805769,"startTime":"0","endTime":"0","summary":"Embark Early Education  has secured a AU$4 million investment commitment from a US-based institutional investor through the placement of 10 million fully paid ordinary shares at AU$0.40 each, according to a Tuesday Australian bourse filing.The new shares will bring the company's total issued share capital to 213.7 million shares and will carry the same rights as the existing shares, per the filing.The funds will be used to partly fund cash consideration for potential asset acquisition opportunities that are yet to be identified and to cover the transaction costs associated with the placement, the filing added.The company's shares rose 2% in recent Tuesday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO.AU","BK7132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656555300","title":"Embark Early Education - Receives A$4.0 Mln Placement Commitment at A$0.40 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2656555300","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656555300?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:23","pubTimestamp":1785795795,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nFWN44012G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVO.AU","BK7132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651504445","title":"Berenberg Downgrades Evotec to Hold From Buy, Cuts Price Target to EUR3.60 From EUR9.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2651504445","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651504445?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:35","pubTimestamp":1784198122,"startTime":"0","endTime":"0","summary":"Evotec's (EVO) German stock has an average rating of overweight and mean price target of EUR5.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO","BK7132","BK4121","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647452532","title":"Evotec Expands Prefabricated Drug Manufacturing Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2647452532","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647452532?lang=en_us&edition=fundamental","pubTime":"2026-06-30 18:20","pubTimestamp":1782814859,"startTime":"0","endTime":"0","summary":"Evotec  has expanded its Just-Evotec Biologics services with J.TRAIN, a new offering that lets biopharmaceutical companies use Evotec's manufacturing technology within their own facilities on a turnkey basis, the company said Tuesday.J.TRAIN includes prefabricated modular cleanrooms and manufacturing equipment with Just - Evotec Biologics' process automation, allowing for faster and more cost-effective deployment, the company said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7132","EVO.AU","BK4121","EVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636824046","title":"Embark Early Education Declares Further Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2636824046","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636824046?lang=en_us&edition=fundamental","pubTime":"2026-05-18 11:33","pubTimestamp":1779075198,"startTime":"0","endTime":"0","summary":"Embark Early Education  declared a further quarterly dividend of AU$0.015 per share as its final dividend for 2025, according to a Monday Australian bourse filing.The dividend will be paid on June 15 to holders of record as of May 26, the filing said.The company's shares rose around 2% in recent Monday trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VIG","BK4585","BK7132","EVO.AU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636043831","title":"Embark Early Education Declares QTRLY Dividend Of A$0.015/Share As Final Dividend For Fy2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2636043831","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636043831?lang=en_us&edition=fundamental","pubTime":"2026-05-18 10:16","pubTimestamp":1779070577,"startTime":"0","endTime":"0","summary":"May 18 (Reuters) - Embark Early Education Ltd ::*DECLARES QTRLY DIVIDEND OF AUD0.015 PER SHARE AS FINAL DIVIDEND FOR FY2025*Further company coverage: EVO.AX* ((Reuters.Briefs@thomsonreuters.com;))  ((","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nRSD5jRWyQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVO.AU","BK7132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636801115","title":"Embark Early Education Ltd - Declares Qtrly Dividend of AUD0.015 per Share as Final Dividend for FY2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2636801115","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636801115?lang=en_us&edition=fundamental","pubTime":"2026-05-18 06:23","pubTimestamp":1779056598,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260517:nFWN41T00P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7132","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632393605","title":"Evotec, Almirall Nominate First Preclinical Development Candidate in Dermatology Partnership; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2632393605","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632393605?lang=en_us&edition=fundamental","pubTime":"2026-05-04 16:12","pubTimestamp":1777882376,"startTime":"0","endTime":"0","summary":"Evotec  said Monday it has nominated the first small molecule preclinical development candidate from its multi-target drug discovery collaboration in medical dermatology with Almirall.The partnership intends to create novel treatments for immune-mediated inflammatory skin diseases.The company said it will continue to support the program toward investigational new drug submission.Evotec shares were up 2.9% in premarket activity.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4121","EVO","BK7132","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631448689","title":"Evotec Secures Grants for Tuberculosis Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2631448689","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631448689?lang=en_us&edition=fundamental","pubTime":"2026-04-30 17:08","pubTimestamp":1777540114,"startTime":"0","endTime":"0","summary":"Evotec  secured two new grants from the Gates Foundation for tuberculosis drug discovery and development, the company said Thursday.The funding will support expansion of novel tuberculosis drug candidates and help advance selected drug combinations toward clinical evaluation, the company said.The first grant will focus on developing novel small molecule therapies using its artificial intelligence-enabled drug discovery platform, while the second grant will support nonclinical evaluation of next-generation drug combinations, including long-acting injectables.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO","BK7132","BK4121","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629133268","title":"Evotec Names Claire Hinshelwood Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629133268","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629133268?lang=en_us&edition=fundamental","pubTime":"2026-04-24 15:31","pubTimestamp":1777015905,"startTime":"0","endTime":"0","summary":"Evotec  said Friday that Chief Financial Officer Paul Hitchin will exit his post on April 30 and Claire Hinshelwood is prepared to take over the vacancy starting May 1.The incoming executive has over 30 years of management history, including senior leadership at Novartis , and Hitchin decided to depart for private reasons unrelated to business performance, Evotec said.Shares of the company were down 2.1% in Friday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO","IE00B4R5TH58.HKD","BK7132","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","BK4121","BK4532","LU0208291251.USD","EVO.AU","IE00B2B36J28.USD","LU0070302665.USD","NVS","BK4585","LU0320765489.SGD","IE00BJT1NW94.SGD","BK4578","BK4588","LU0211331839.USD","BK4007","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627406420","title":"Evotec Names Ingrid Muller Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2627406420","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627406420?lang=en_us&edition=fundamental","pubTime":"2026-04-15 15:07","pubTimestamp":1776236873,"startTime":"0","endTime":"0","summary":"Evotec  said Wednesday it appointed Ingrid Muller as chief operating officer, effective May 1.Muller has more than 20 years of experience in international leadership in the life sciences industry. She most recently served as vice president portfolio strategy and execution at CureVac.In her new role, she will oversee the company's global operations and implementation of the Horizon initiative.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7132","EVO","EVO.AU","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625291107","title":"Evotec Q4 Revenue Rises; 2026 Sales Outlook Set; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2625291107","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625291107?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:03","pubTimestamp":1775639012,"startTime":"0","endTime":"0","summary":"Evotec  reported Q4 revenue Wednesday of 253.3 million euros , up from 221.2 million euros a year earlier.One analyst surveyed by FactSet expected 252.6 million euros.The company expects 2026 revenue of about 700 million euros to 780 million euros. Analysts polled by FactSet expect 785.1 million euros.Evotec shares were up 8.5% in premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO","BK7132","BK4121","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625919659","title":"GUIDANCE: (EVO) Evotec SE Expects 2026 Revenue Range 700M Euros to 780M Euros","url":"https://stock-news.laohu8.com/highlight/detail?id=2625919659","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625919659?lang=en_us&edition=fundamental","pubTime":"2026-04-08 16:32","pubTimestamp":1775637145,"startTime":"0","endTime":"0","summary":"GUIDANCE: (EVO) Evotec SE Expects 2026 Revenue Range 700M Euros to 780M Euros","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625919363","title":"Earnings Flash (EVO) Evotec Posts Q4 Revenue 253.3M Euros","url":"https://stock-news.laohu8.com/highlight/detail?id=2625919363","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625919363?lang=en_us&edition=fundamental","pubTime":"2026-04-08 16:30","pubTimestamp":1775637002,"startTime":"0","endTime":"0","summary":"Earnings Flash (EVO) Evotec Posts Q4 Revenue 253.3M Euros","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO","EVO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621773682","title":"Evotec Unit Selected to Optimize Manufacturing for Antibody Cocktail","url":"https://stock-news.laohu8.com/highlight/detail?id=2621773682","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621773682?lang=en_us&edition=fundamental","pubTime":"2026-03-23 15:58","pubTimestamp":1774252737,"startTime":"0","endTime":"0","summary":"Evotec  said Monday its biologics unit, Just - Evotec Biologics, was selected by a US government program to advance manufacturing optimization for viruses like Ebola virus and Sudan virus.The company said the deal, worth up to $10 million with a base period and two option periods, comes from a consortium backed by the Biomedical Advanced Research and Development Authority.The work will focus on refining two antibodies discovered in survivors of the 2014 Ebola outbreak and developing efficient ways to produce them at scale, it added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EVO.AU","BK4121","BK7132","EVO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}